Vicore Pharma Holding AB
VICO SE0007577895
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-55% | 18% | -20% | -41% | 8% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Ahmed Mousa CEO |
8.24 SEK |
11,034 Bought |
90,920 SEK |
15/05/2025 | 13/05/2025 |
Ahmed Mousa CEO |
8.23 SEK |
757 Bought |
6,230 SEK |
15/05/2025 | 13/05/2025 |
Johannes Schikan CB |
7.70 SEK |
10,000 Bought |
77,000 SEK |
12/05/2025 | 08/05/2025 |
Johannes Schikan CB |
7.80 SEK |
10,000 Bought |
78,000 SEK |
12/05/2025 | 08/05/2025 |
Johannes Schikan CB |
7.90 SEK |
10,000 Bought |
79,000 SEK |
12/05/2025 | 08/05/2025 |
Ann Barbier DIR |
7.03 SEK |
42,500 Bought |
298,775 SEK |
24/09/2024 | 23/09/2024 |
Ahmed Mousa CEO |
7.76 SEK |
32,000 Bought |
248,170 SEK |
11/09/2024 | 11/09/2024 |
Ahmed Mousa CEO |
7.92 SEK |
95,000 Bought |
752,248 SEK |
11/09/2024 | 10/09/2024 |
Jacob Uno Stanley Gunterberg CB |
34.50 SEK |
6,400 Bought |
220,800 SEK |
08/06/2022 | 08/06/2022 |
Sara Malcus DIR |
30.15 SEK |
2,902 Bought |
87,495 SEK |
03/06/2022 | 03/06/2022 |